Takip et
Ezgi Oner
Ezgi Oner
Post-doctoral Research Fellow at Trinity College Dublin
tcd.ie üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
E Oner, M Kotmakci, AM Baird, SG Gray, B Debelec Butuner, E Bozkurt, ...
Journal of Nanobiotechnology 19 (71), 1-20, 2021
352021
Nutlin3a-loaded nanoparticles show enhanced apoptotic activity on prostate cancer cells
B Debelec-Butuner, M Kotmakci, E Oner, G Ozduman, AG Kantarci
Molecular biotechnology 61, 489-497, 2019
112019
A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability
E Oner, M Kotmakci, AG Kantarci
Pharmaceutical Development and Technology 25 (8), 936-948, 2020
92020
SIRT1 siRNA-loaded lipid nanoparticles enhanced doxorubicin-induced cell death in prostate cancer cell lines
B Debelec-Butuner, E Oner, M Kotmakci, AG Kantarci
Journal of Drug Delivery Science and Technology 66, 102670, 2021
52021
Cell Viability Assay with 3D Prostate Tumor Spheroids
E Oner, SG Gray, SP Finn
Cancer Cell Culture: Methods and Protocols, 263-275, 2023
22023
Nanoconjugate formulations for enhanced drug delivery
E Oner, M Ilhan, HE Gultekin, M Karpuz
Advanced and Modern Approaches for Drug Delivery, 441-491, 2023
12023
Nanovesicles for intravenous drug delivery
HE Gültekin, E Oner, M İlhan, M Karpuz
Applications of Nanovesicular Drug Delivery, 115-148, 2022
12022
1342 Longitudinal detection of circulating tumour cells in serous and non-serous epithelial ovarian carcinomas
F Lewis, M Ward, C O’Gorman, B Henderson, S Hurley, J Beirne, ...
International Journal of Gynecologic Cancer 34 (Suppl 1), 2024
2024
68Ga‐labeled, imatinib encapsulated, theranostic liposomes: Formulation, characterization, and in vitro evaluation of anticancer activity
M Karpuz, E Ozgenc, E Oner, E Atlihan‐Gundogdu, Z Burak
Drug Development Research 85 (1), e22136, 2024
2024
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
VM Saini, E Oner, M Ward, S Hurley, BD Henderson, F Lewis, SP Finn, ...
bioRxiv, 2024.02. 05.578972, 2024
2024
Evaluation of Parsortix PR1 and PX+ Systems for the Isolation of Circulating Tumour Cells in Patients With Resectable Lung Cancer
VM Saini, E Oner, S Hurley, S Nicholson, L O'Driscoll, S Finn, ...
The Journal of Liquid Biopsy 1, 2023
2023
siRNA yüklü ilaç taşıyıcı sistem geliştirilmesi ve anti-kanser etkisinin in vitro değerlendirilmesi
E Öner
Marmara Üniversitesi Sağlık Bilimleri Enstitüsü, 2020
2020
Evaluation of the cationic solid lipid nanoparticles carrying siRNA against EphA2 receptor as non-viral delivery systems
E Oner, M Kotmakci, SG Gray, AM Baird, B Debelec Butuner, AG Kantarci, ...
HUMAN GENE THERAPY 30 (11), A200-A201, 2019
2019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–13